Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO906 in advanced breast cancer
NCT00035126Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2002
- Primary completion
- Nov 2003
- Modality
- Covalent Small Molecules, RNA-Targeting Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patupilone in breast cancer, sponsored by Novartis. Started Jan 2002; status: completed.
02
Drugs
patupilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00035126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035126.